Thomas Kerbusch
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Statistics and Probability top 2%
- Statistical Methods in Clinical Trials
Papers in
-
- Chemotherapy-induced organ toxicity mitigation 15
-
- Statistical Methods in Clinical Trials 8
- Co-authors
- Mats O. Karlsson (3 shared papers)Radojka M. Savić (1 shared paper)Daniël M. Jonker (1 shared paper)Jos H. Beijnen (12 shared papers)Meindert Danhof (5 shared papers)Alwin D. R. Huitema (9 shared papers)D. A. Flockhart (1 shared paper)Zereunesay Desta (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (6 papers)CPT Pharmacometrics & Systems Pharmacology (4 papers)Clinical Pharmacology & Therapeutics (4 papers)Clinical Pharmacokinetics (4 papers)Journal of Pharmacokinetics and Pharmacodynamics (3 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Thomas Kerbusch
47 papers receiving 1.9k citations
Thomas Kerbusch's Hit Papers
Peers
Comparison fields: 5 of 140
- Pharmacology 318
- Statistics and Probability 179
- Health Informatics 23
- Pathology and Forensic Medicine 224
- Pharmacology 189
Countries citing papers authored by Thomas Kerbusch
This map shows the geographic impact of Thomas Kerbusch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kerbusch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kerbusch more than expected).
Fields of papers citing papers by Thomas Kerbusch
This network shows the impact of papers produced by Thomas Kerbusch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kerbusch. The network helps show where Thomas Kerbusch may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Kerbusch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 413 | |
| 2 | Good Practices in Model‐Informed Drug Discovery and Development: Practice, Application, and Documentation Hit paper breakdown → | 2015 | 276 |
| 3 | 2001 | 108 | |
| 4 | 1999 | 103 | |
| 5 | 2014 | 79 | |
| 6 | 2020 | 68 | |
| 7 | 1998 | 64 | |
| 8 | 1998 | 64 | |
| 9 | 2000 | 59 | |
| 10 | 2009 | 55 | |
| 11 | 2003 | 46 | |
| 12 | 2000 | 43 | |
| 13 | 2011 | 43 | |
| 14 | 2010 | 41 | |
| 15 | 2000 | 39 | |
| 16 | 2001 | 36 | |
| 17 | 2016 | 31 | |
| 18 | Influence of dose and infusion duration on pharmacokinetics of ifosfamide and metabolites. | 2001 | 29 |
| 19 | 2003 | 28 | |
| 20 | 2013 | 27 |
About Thomas Kerbusch
Thomas Kerbusch is a scholar working on Pathology and Forensic Medicine, Statistics and Probability, Pediatrics, Perinatology and Child Health, Molecular Biology and Pharmacology, having authored 49 papers that have together received 2.0k indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (15 papers), Statistical Methods in Clinical Trials (8 papers), Pharmacogenetics and Drug Metabolism (5 papers), Pharmacological Effects and Toxicity Studies (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Computational Drug Discovery Methods (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Pharmacology (318 citations), Statistics and Probability (179 citations), Health Informatics (23 citations), Pathology and Forensic Medicine (224 citations) and Pharmacology (189 citations). Thomas Kerbusch has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Mats O. Karlsson, Radojka M. Savić, Daniël M. Jonker, Jos H. Beijnen, Meindert Danhof, Alwin D. R. Huitema, D. A. Flockhart, Zereunesay Desta, H.J. Keizer and Rik de Greef. Their work appears in journals such as British Journal of Clinical Pharmacology, CPT Pharmacometrics & Systems Pharmacology, Clinical Pharmacology & Therapeutics, Clinical Pharmacokinetics and Journal of Pharmacokinetics and Pharmacodynamics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.